Global Non-prescription Drugs Professional Survey Report 2023, Forecast to 2028

The Non-prescription Drugs report equips organizations with a comprehensive understanding of market dynamics, facilitating the formulation of strategic plans based on opportunities and informed decisions. In addition to business descriptions, growth projections, and market performance of key vendors in various regions, the report examines potential industry trends. Insights from industry experts aid in future-oriented decision-making, ensuring competitiveness. This research is a valuable resource. The report emphasizes critical aspects such as market size, share, trends, and drivers within prominent industry segments and geographic locations. It empowers enterprises with insights into challenges, opportunities, pricing strategies, company metrics, supply chains, and technological advancements.

For the Non-prescription Drugs market, the use scenario and thinking of AI

2023 is set to be a revolutionary year for Artificial Intelligence. With the continued development of AI technology, more and more businesses are beginning to invest in the potential of AI to automate processes and increase efficiency.

The report researches and analyzes the influence of the Non-prescription Drugs industry in the new era of global post-COIVD-19 economy in 2023, and provides in-depth analysis and professional suggestions on the current development.

Non-prescription Drugs Market Competition list

    Pfizer
    Roche
    Sanofi
    Johnson & Johnson
    Merck & Co. (MSD)
    Novartis
    AbbVie
    Gilead Sciences
    GlaxoSmithKline (GSK)
    Amgen
    AstraZeneca
    Bristol-Myers Squibb
    Eli Lilly
    Teva
    Bayer
    Novo Nordisk
    Allergan
    Shire

(Find more companies in our free sample!)

Market Segment by Product Type

Brand Drugs
Generic Drug
......

Market Segment by Product Application

Hospital
Clinic
Other
......

Market segment by Region, regional analysis covers

Bottom-up and Top-down Approaches for This Report

Table of Contents

Global Non-prescription Drugs Market Report 2023, Forecast to 2028

1 Report Overview
1.1 Non-prescription Drugs Introduction
1.2 Report Structure Overview
1.3 Years Considered

2 Market Status
2.1 Global Non-prescription Drugs Market Outlook
2.2 Key Industry Perspective: What Industry Leaders are saying?
2.3 Global Demand Side Trends
2.4 Global Supply Side Trends
2.5 Value Chain Analysis
2.5.1 Raw Material Suppliers
2.5.2 Non-prescription Drugs Manufacturers
2.5.3 Distributors
2.6 Macro-Economic Factors
2.6.1 Global GDP Growth
2.6.2 Manufacturing Value Added
2.6.3 Industrial Production
2.7 Forecast Factors – Relevance & Impact
2.8 Market Dynamics
2.8.1 Market Opportunities
2.8.2 Market Risk
2.8.3 Market Driving Force
2.8.4 Product Innovation / Development Trends

3 Coronavirus Disease 2020 (COVID-19): Non-prescription Drugs Industry Impact
3.1 Current Statistics and Probable Future Impact
3.2 Comparison of SAARs and Market Recovery
3.3 Non-prescription Drugs Business Impact Assessment – Covid-19
3.4 Market Trends and Non-prescription Drugs Potential Opportunities in the COVID-19 Landscape

4 Production by Region
4.1 Global Non-prescription Drugs Production (History Data) by Region (2018-2023)
4.2 Global Non-prescription Drugs Production Value (History Data) by Region
4.3 North America
4.3.1 North America Non-prescription Drugs Production Growth Rate 2018-2023
4.3.2 North America Non-prescription Drugs Production Value Growth Rate 2018-2023
4.3.3 Key Players in North America
4.3.4 North America Non-prescription Drugs Import & Export
4.4 Europe
4.4.1 Europe Non-prescription Drugs Production Growth Rate 2018-2023
4.4.2 Europe Non-prescription Drugs Production Value Growth Rate 2018-2023
4.4.3 Key Players in Europe
4.4.4 Europe Non-prescription Drugs Import & Export
4.5 Japan
4.5.1 Japan Non-prescription Drugs Production Growth Rate 2018-2023
4.5.2 Japan Non-prescription Drugs Production Value Growth Rate 2018-2023
4.5.3 Key Players in Japan
4.5.4 Japan Non-prescription Drugs Import & Export
4.6 China
4.6.1 China Non-prescription Drugs Production Growth Rate 2018-2023
4.6.2 China Non-prescription Drugs Production Value Growth Rate 2018-2023
4.6.3 Key Players in China
4.6.4 China Non-prescription Drugs Import & Export
4.7 Southeast Asia
4.7.1 Southeast Asia Non-prescription Drugs Production Growth Rate 2018-2023
4.7.2 Southeast Asia Non-prescription Drugs Production Value Growth Rate 2018-2023
4.7.3 Key Players in Southeast Asia
4.7.4 Southeast Asia Non-prescription Drugs Import & Export
4.8 India
4.8.1 India Non-prescription Drugs Production Growth Rate 2018-2023
4.8.2 India Non-prescription Drugs Production Value Growth Rate 2018-2023
4.8.3 Key Players in India
4.8.4 India Non-prescription Drugs Import & Export

5 Non-prescription Drugs Consumption by Region
5.1 Global Non-prescription Drugs Consumption (History Data) by Region
5.2 North America
5.2.1 North America Non-prescription Drugs Consumption by Type
5.2.2 North America Non-prescription Drugs Consumption by Application
5.2.3 North America Non-prescription Drugs Consumption by Countries
5.2.4 United States
5.2.5 Canada
5.2.6 Mexico
5.3 Europe
5.3.1 Europe Non-prescription Drugs Consumption by Type
5.3.2 Europe Non-prescription Drugs Consumption by Application
5.3.3 Europe Non-prescription Drugs Consumption by Countries
5.3.4 Germany
5.3.5 France
5.3.6 UK
5.3.7 Italy
5.3.8 Russia
5.3.9 Spain
5.4 Asia Pacific
5.4.1 Asia Pacific Non-prescription Drugs Consumption by Type
5.4.2 Asia Pacific Non-prescription Drugs Consumption by Application
5.4.3 Asia Pacific Non-prescription Drugs Consumption by Region
5.4.4 China
5.4.5 Japan
5.4.6 South Korea
5.4.7 India
5.4.8 Australia
5.4.9 Spain
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Non-prescription Drugs Consumption by Type
5.5.2 Central & South America Non-prescription Drugs Consumption by Application
5.5.3 Central & South America Non-prescription Drugs Consumption by Countries
5.5.4 Brazil
5.6 Middle East and Africa
5.6.1 Middle East and Africa Non-prescription Drugs Consumption by Type
5.6.2 Middle East and Africa Non-prescription Drugs Consumption by Application
5.6.3 Middle East and Africa Non-prescription Drugs Consumption by Countries
5.6.4 GCC Countries
5.6.5 Turkey
5.6.6 Egypt
5.6.7 South Africa
5.6.8 Israel

6 Global Non-prescription Drugs Market Segment by Type
6.1 Introduction / Key Findings
6.2 Global Non-prescription Drugs Revenue, Sales and Market Share by Type (2018-2023)
6.2.1 Global Non-prescription Drugs Sales and Market Share by Type (2018-2023)
6.2.2 Global Non-prescription Drugs Revenue and Market Share by Type (2018-2023)
6.3 Brand Drugs Sales Growth Rate and Price
6.3.1 Global Brand Drugs Sales Growth Rate (2018-2023)
6.3.2 Global Brand Drugs Price (2018-2023)
6.4 Generic Drug Sales Growth Rate and Price
6.4.1 Global Generic Drug Sales Growth Rate (2018-2023)
6.4.2 Global Generic Drug Price (2018-2023)

7 Global Non-prescription Drugs Market Segment by Application
7.1 Introduction / Key Findings
7.2 Global Non-prescription Drugs Sales Market Share by Application (2018-2023)
7.3 Hospital Sales Growth Rate (2018-2023)
7.4 Clinic Sales Growth Rate (2018-2023)
7.5 Other Sales Growth Rate (2018-2023)

8 Analysis of Key Players
8.1 Pfizer
8.1.1 Company Details
8.1.2 Description and Business Overview
8.1.3 Product Introduction
8.1.4 Pfizer Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.1.5 Recent News
8.2 Roche
8.2.1 Company Details
8.2.2 Description and Business Overview
8.2.3 Product Introduction
8.2.4 Roche Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.2.5 Recent News
8.3 Sanofi
8.3.1 Company Details
8.3.2 Description and Business Overview
8.3.3 Product Introduction
8.3.4 Sanofi Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.3.5 Recent News
8.4 Johnson & Johnson
8.4.1 Company Details
8.4.2 Description and Business Overview
8.4.3 Product Introduction
8.4.4 Johnson & Johnson Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.4.5 Recent News
8.5 Merck & Co. (MSD)
8.5.1 Company Details
8.5.2 Description and Business Overview
8.5.3 Product Introduction
8.5.4 Merck & Co. (MSD) Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.5.5 Recent News
8.6 Novartis
8.6.1 Company Details
8.6.2 Description and Business Overview
8.6.3 Product Introduction
8.6.4 Novartis Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.6.5 Recent News
8.7 AbbVie
8.7.1 Company Details
8.7.2 Description and Business Overview
8.7.3 Product Introduction
8.7.4 AbbVie Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.7.5 Recent News
8.8 Gilead Sciences
8.8.1 Company Details
8.8.2 Description and Business Overview
8.8.3 Product Introduction
8.8.4 Gilead Sciences Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.8.5 Recent News
8.9 GlaxoSmithKline (GSK)
8.9.1 Company Details
8.9.2 Description and Business Overview
8.9.3 Product Introduction
8.9.4 GlaxoSmithKline (GSK) Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.9.5 Recent News
8.10 Amgen
8.10.1 Company Details
8.10.2 Description and Business Overview
8.10.3 Product Introduction
8.10.4 Amgen Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.10.5 Recent News
8.11 AstraZeneca
8.11.1 Company Details
8.11.2 Description and Business Overview
8.11.3 Product Introduction
8.11.4 AstraZeneca Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.11.5 Recent News
8.12 Bristol-Myers Squibb
8.12.1 Company Details
8.12.2 Description and Business Overview
8.12.3 Product Introduction
8.12.4 Bristol-Myers Squibb Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.12.5 Recent News
8.13 Eli Lilly
8.13.1 Company Details
8.13.2 Description and Business Overview
8.13.3 Product Introduction
8.13.4 Eli Lilly Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.13.5 Recent News
8.14 Teva
8.14.1 Company Details
8.14.2 Description and Business Overview
8.14.3 Product Introduction
8.14.4 Teva Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.14.5 Recent News
8.15 Bayer
8.15.1 Company Details
8.15.2 Description and Business Overview
8.15.3 Product Introduction
8.15.4 Bayer Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.15.5 Recent News
8.16 Novo Nordisk
8.16.1 Company Details
8.16.2 Description and Business Overview
8.16.3 Product Introduction
8.16.4 Novo Nordisk Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.16.5 Recent News
8.17 Allergan
8.17.1 Company Details
8.17.2 Description and Business Overview
8.17.3 Product Introduction
8.17.4 Allergan Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.17.5 Recent News
8.18 Shire
8.18.1 Company Details
8.18.2 Description and Business Overview
8.18.3 Product Introduction
8.18.4 Shire Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.18.5 Recent News
8.19 Boehringer Ingelheim
8.19.1 Company Details
8.19.2 Description and Business Overview
8.19.3 Product Introduction
8.19.4 Boehringer Ingelheim Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.19.5 Recent News
8.20 Takeda
8.20.1 Company Details
8.20.2 Description and Business Overview
8.20.3 Product Introduction
8.20.4 Takeda Non-prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.20.5 Recent News

9 Non-prescription Drugs Market Forecast
9.1 Forecast Factors – Relevance & Impact
9.1.1 Factor 1
9.1.2 Factor 2
9.1.3 Factor 3
9.2 Global Non-prescription Drugs Revenue, Sales and Growth Rate (2023-2028)
9.3 Non-prescription Drugs Market Forecast by Regions (2023-2028)
9.3.1 North America Non-prescription Drugs Market Forecast (2023-2028)
9.3.2 Europe Non-prescription Drugs Market Forecast (2023-2028)
9.3.3 Asia-Pacific Non-prescription Drugs Market Forecast (2023-2028)
9.3.4 South America Non-prescription Drugs Market Forecast (2023-2028)
9.3.5 Middle East & Africa Non-prescription Drugs Market Forecast (2023-2028)
9.4 Non-prescription Drugs Market Forecast by Type (2023-2028)
9.4.1 Global Non-prescription Drugs Consumption Forecast by Type (2023-2028)
9.4.2 Global Non-prescription Drugs Consumption Market Share Forecast by Type (2023-2028)
9.5 Non-prescription Drugs Market Forecast by Application (2023-2028)
9.5.1 Global Non-prescription Drugs Consumption Forecast by Application (2023-2028)
9.5.2 Global Non-prescription Drugs Market Share Forecast by Application (2023-2028)

10 Conclusion